Benoxaprofen
From Self-sufficiency
| File:Benoxaprofen structure.png | |
| Systematic (IUPAC) name | |
|---|---|
|
2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid | |
| Identifiers | |
| CAS Number | 67434-14-4 |
| ATC code | M01AE06 (WHO) |
| PubChem | CID 39941 |
| Chemical data | |
| Formula | C16H12ClNO3 |
| Molar mass | 301.72438 g/mol[[Script error: No such module "String".]] |
Benoxaprofen is a non-steroidal anti-inflammatory drug. It was marketed by Eli Lilly and Company under the brand name Oraflex in the US and as Opren in Europe. Lilly suspended sales of Oraflex in 1982 after reports from the British government and the U.S. Food and Drug Administration of adverse effects and deaths linked to the drug.
References
| 45px | This drug article relating to the musculoskeletal system is a stub. You can help ssf by expanding it. |
| 40px | This analgesic-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Carboxylic acids
- Eli Lilly and Company
- Benzoxazoles
- Organochlorides
- Musculoskeletal system drug stubs
- Analgesic stubs
